Table 2: Incident rate of CV events in 86 patients treated with anti-TNF alfa (TNF+) and 258 patients treated with DMARDs (TNF-).

Exposure n. patients Patient-years (×100) CV events/100 patients/year
TNF+ 86 855.87 2.4
TNF- 258 3452.62 1.27